ELVN   $24.47  -3.70% Market Closed After Close 24.54 0.29%

Enliven Therapeutics Inc
Total Cash 312.39M
totalCashPerShare 6.613
EBITDA -95.95M
Total Debt 169.00K
quickRatio 14.132
currentRatio 14.392
Total Revenue
debtToEquity 0.055
Revenue/Share
ROA -0.19549
ROE -0.28369
grossProfits
freeCashflow -31.10M
operatingCashflow -72.17M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 1.00B
forwardPE -11.658228
floatShares 24.98M
sharesOutstanding 47.24M
sharesShort 6.51M
sharesShortPriorMonth 5.53M
dateShortInterest
sharesPercentSharesOut 0.14%
heldPercentInsiders 0.07%
heldPercentInstitutions 1.03%
Short Ratio help_outline 18.76%
shortPercentOfFloat 0.34%
impliedSharesOutstanding
bookValue 6.464
Price To Book help_outline 4.27
earningsQuarterlyGrowth
netIncomeToCommon -82.83M
trailingEps -1.91%
forwardEps -2.37%
enterpriseToEbitda -10.46
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.5 3Q 2024
institutionsCount 150
lastUpdated Nov. 2, 2024, 4:12 a.m.